Euclidean Capital is a New York-based family office and investment firm that makes direct venture investments in U.S. private companies. It invests from seed through later-stage venture rounds, including Series A, Series B and Series C financings, with sector exposure across biotechnology, life sciences, pharmaceuticals, fintech, AI, robotics, automation, drones, climate and energy.